Mohamed Genead
Vorstandsvorsitzender bei Aviceda Therapeutics, Inc.
Profil
Mohamed A.
Genead is the founder of Aviceda Therapeutics, Inc. He is currently the Chairman, President & Chief Executive Officer of Aviceda Ophthalmics, Inc. He was previously the Director-Center of Retina Degenerative Diseases at the University of Illinois and the Chief Medical Officer at Ocugen, Inc. In 2017, he briefly served as the Chief Medical Officer at Gensight Biologics SA.
Aktive Positionen von Mohamed Genead
| Unternehmen | Position | Beginn |
|---|---|---|
Aviceda Therapeutics, Inc.
 Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Vorstandsvorsitzender | - |
Aviceda Ophthalmics, Inc.
 Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Mohamed Genead
| Unternehmen | Position | Ende |
|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2017 |
| University of Illinois | Corporate Officer/Principal | - |
| OCUGEN, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| OCUGEN, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Commercial Services |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Health Technology |
